• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Dolby Laboratories

    11/13/24 4:05:17 PM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous
    Get the next $DLB alert in real time by email
    SC 13G/A 1 fp0090889-10_sc13ga.htm

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED

    PURSUANT TO RULE 13d-2(b)

     

    (AMENDMENT NO. 2)*

     

    DOLBY LABORATORIES, INC.

     

    (Name of Issuer)

     

    Common Stock

     

    (Title of Class of Securities)

     

    25659T107

     

    (CUSIP Number)

     

    September 30, 2024

     

    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    [X] Rule 13d-1(b) 

    [  ] Rule 13d-1(c) 

    [  ] Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

    CUSIP No. 25659T107   13G   Page 2 of 5 Pages

     

    1.

    NAMES OF REPORTING PERSONS OR 

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

    Kayne Anderson Rudnick Investment Management, LLC 

    95-4575414

     
    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 

    (see instructions) 

    (a) [   ]

    (b) [   ]

    3.

    SEC USE ONLY

     

     
    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION 

     

    A California Limited Liability Company

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON WITH

    5.

    SOLE VOTING POWER 

    189,912

    6.

    SHARED VOTING POWER

    2,455

    7.

    SOLE DISPOSITIVE POWER

    206,197

    8.

    SHARED DISPOSITIVE POWER

    2,455

    9.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 

    208,652

     
    10.

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES 

    (see instructions) [   ] 

     

     
    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 

    0.35%

     
    12.

    TYPE OF REPORTING PERSON (see instructions)

     

    IA

     

     

     

    CUSIP No. 25659T107   13G   Page 3 of 5 Pages

     

    Item 1. (a)

    Name of Issuer

    Dolby Laboratories, Inc.

         
      (b)

    Address of Issuer’s Principal Executive Offices

    1275 Market Street, San Francisco, CA 94103

     

    Item 2. (a)

    Name of Person Filing

    Kayne Anderson Rudnick Investment Management, LLC

         
      (b)

    Address of the Principal Office or, if none, residence

    2000 Avenue of the Stars, Suite 1110, Los Angeles, CA 90067

         
      (c)

    Citizenship

    A California Limited Liability Company

         
      (d)

    Title of Class of Securities

    Common Stock

         
      (e)

    CUSIP Number

    25659T107

     

    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

      (a) [  ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
           
      (b) [  ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
           
      (c) [  ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
           
      (d) [  ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
           
      (e) [X] An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
           
      (f) [  ] An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
           
      (g) [  ] A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
           
      (h) [  ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
           
      (i) [  ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
           
      (j) [  ] Group, in accordance with §240.13d-1(b)(1)(ii)(J).

     

     

    CUSIP No. 25659T107   13G   Page 4 of 5 Pages

     

    Item 4. Ownership.

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

    (a) Amount beneficially owned: 208,652
    (b) Percent of class: 0.35%
    (c) Number of shares as to which the person has:
      (i) Sole power to vote or to direct the vote: 189,912
      (ii) Shared power to vote or to direct the vote: 2,455
      (iii) Sole power to dispose or to direct the disposition of: 206,197
      (iv) Shared power to dispose or to direct the disposition of: 2,455

     

    Item 5. Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ X ].

    Instruction. Dissolution of a group requires a response to this item.

     

    The reporting person has ceased to be the beneficial owner of more than five percent of the class of securities.

     

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.

     

    N/A

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

     

    N/A

     

    Item 8. Identification and Classification of Members of the Group.

     

    N/A

     

    Item 9. Notice of Dissolution of Group.

     

    N/A

     

     

    CUSIP No. 25659T107   13G   Page 5 of 5 Pages

     

    Item 10. Certification.

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

    Signature

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

      Kayne Anderson Rudnick Investment Management, LLC
           
      By: /s/ Michael Shoemaker  
      Name: Michael Shoemaker
      Title: Chief Compliance Officer
      Date: November 13, 2024
    Get the next $DLB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DLB

    DatePrice TargetRatingAnalyst
    6/3/2024$100.00Mkt Perform → Outperform
    Barrington Research
    11/18/2022Outperform → Mkt Perform
    Barrington Research
    5/24/2022$90.00Buy
    Rosenblatt
    8/2/2021$115.00Mkt Perform → Outperform
    Barrington Research
    More analyst ratings

    $DLB
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Dolby Laboratories Reports Second Quarter 2025 Financial Results

      SAN FRANCISCO, May 1, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the second quarter of fiscal 2025. "We had a strong second quarter with continued momentum across our end markets, especially in Auto and Mobile," said Kevin Yeaman, President and CEO, Dolby Laboratories. "While there is economic uncertainty, we are well positioned to operate across a range of scenarios. We are in a strong financial position, we continue to see strong engagement from our ecosystem, and we remain focused on driving long-term growth.

      5/1/25 4:15:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Laboratories Announces Conference Call and Webcast for Q2 Fiscal 2025 Financial Results

      SAN FRANCISCO, April 8, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, will release financial results for the second quarter (Q2) fiscal year 2025 after the close of regular trading on Thursday, May 1, 2025. Members of Dolby management will lead a conference call open to all interested parties to discuss Q2 fiscal year 2025 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Thursday, May 1, 2025. Access to the teleconference will be available at http://investor.dolby.com or by dialing 1-888-21

      4/8/25 4:15:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby and AMC Entertainment announce major expansion of Dolby Cinema at AMC in the US, with 40 additional auditoriums to be added by the end of 2027

      AMC has also selected Dolby Vision as its HDR offering of choice SAN FRANCISCO and LEAWOOD, Kan., March 31, 2025 /PRNewswire/ --  Dolby Laboratories, Inc. (NYSE:DLB), a leader in immersive entertainment experiences, and AMC Entertainment (NYSE:AMC), the largest theatrical exhibitor in the United States and in the world, today announced a significant expansion of their partnership, following a decade of success and guest popularity of the Dolby Cinema at AMC experience. Beginning this year, AMC and Dolby will add an additional 40 Dolby Cinema at AMC locations in the United States through the end of 2027.

      3/31/25 8:30:00 AM ET
      $AMC
      $DLB
      Movies/Entertainment
      Consumer Discretionary
      Multi-Sector Companies
      Miscellaneous

    $DLB
    Financials

    Live finance-specific insights

    See more
    • Dolby Laboratories Reports Second Quarter 2025 Financial Results

      SAN FRANCISCO, May 1, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the second quarter of fiscal 2025. "We had a strong second quarter with continued momentum across our end markets, especially in Auto and Mobile," said Kevin Yeaman, President and CEO, Dolby Laboratories. "While there is economic uncertainty, we are well positioned to operate across a range of scenarios. We are in a strong financial position, we continue to see strong engagement from our ecosystem, and we remain focused on driving long-term growth.

      5/1/25 4:15:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Laboratories Announces Conference Call and Webcast for Q2 Fiscal 2025 Financial Results

      SAN FRANCISCO, April 8, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, will release financial results for the second quarter (Q2) fiscal year 2025 after the close of regular trading on Thursday, May 1, 2025. Members of Dolby management will lead a conference call open to all interested parties to discuss Q2 fiscal year 2025 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Thursday, May 1, 2025. Access to the teleconference will be available at http://investor.dolby.com or by dialing 1-888-21

      4/8/25 4:15:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Laboratories Reports First Quarter 2025 Financial Results

      SAN FRANCISCO, Jan. 29, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the first quarter of fiscal 2025. "We are off to a strong start for FY25," said Kevin Yeaman, President and CEO, Dolby Laboratories. "In Q1, Dolby Atmos and Dolby Vision momentum continued across device categories. At CES, many of our device partners announced a wide range of Dolby enabled products, and customers experienced the first Dolby Vision enabled car with Li Auto." First Quarter Fiscal 2025 Financial Highlights Total revenue was $357 mil

      1/29/25 4:15:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous

    $DLB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Dolby Labs upgraded by Barrington Research with a new price target

      Barrington Research upgraded Dolby Labs from Mkt Perform to Outperform and set a new price target of $100.00

      6/3/24 9:17:02 AM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Labs downgraded by Barrington Research

      Barrington Research downgraded Dolby Labs from Outperform to Mkt Perform

      11/18/22 9:17:35 AM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Rosenblatt initiated coverage on Dolby Labs with a new price target

      Rosenblatt initiated coverage of Dolby Labs with a rating of Buy and set a new price target of $90.00

      5/24/22 7:27:36 AM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous

    $DLB
    SEC Filings

    See more
    • SEC Form 10-Q filed by Dolby Laboratories

      10-Q - Dolby Laboratories, Inc. (0001308547) (Filer)

      5/1/25 4:52:52 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Laboratories filed SEC Form 8-K: Results of Operations and Financial Condition

      8-K - Dolby Laboratories, Inc. (0001308547) (Filer)

      5/1/25 4:15:23 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Amendment: SEC Form SCHEDULE 13G/A filed by Dolby Laboratories

      SCHEDULE 13G/A - Dolby Laboratories, Inc. (0001308547) (Subject)

      4/30/25 10:55:37 AM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous

    $DLB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President and CEO Yeaman Kevin J bought $200 worth of shares (3 units at $78.15) (SEC Form 4)

      4 - Dolby Laboratories, Inc. (0001308547) (Issuer)

      6/25/24 9:28:41 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous

    $DLB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SVP, Entertainment Couling John D sold $50,652 worth of shares (675 units at $75.04), decreasing direct ownership by 0.55% to 121,151 units (SEC Form 4)

      4 - Dolby Laboratories, Inc. (0001308547) (Issuer)

      5/7/25 4:47:24 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • SEC Form 4 filed by President and CEO Yeaman Kevin J

      4 - Dolby Laboratories, Inc. (0001308547) (Issuer)

      2/28/25 4:04:04 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • SVP, Chief Marketing Officer Pendleton Todd exercised 7,286 shares at a strike of $71.07 and sold $1,517,668 worth of shares (18,121 units at $83.75), decreasing direct ownership by 23% to 37,290 units (SEC Form 4)

      4 - Dolby Laboratories, Inc. (0001308547) (Issuer)

      2/21/25 5:17:52 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous

    $DLB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Dolby Laboratories

      SC 13G/A - Dolby Laboratories, Inc. (0001308547) (Subject)

      11/13/24 4:05:17 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Amendment: SEC Form SC 13G/A filed by Dolby Laboratories

      SC 13G/A - Dolby Laboratories, Inc. (0001308547) (Subject)

      9/10/24 4:39:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • SEC Form SC 13G/A filed by Dolby Laboratories (Amendment)

      SC 13G/A - Dolby Laboratories, Inc. (0001308547) (Subject)

      2/13/24 5:02:35 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous

    $DLB
    Leadership Updates

    Live Leadership Updates

    See more
    • OpenSesame Appoints Tamar Elkeles, PhD, and Emily Rollins to its Board of Directors

      OpenSesame today announced it has appointed Tamar Elkeles, PhD, and Emily Rollins to its Board of Directors. Dr. Elkeles is a highly regarded Chief Human Resources Officer and thought leader, advising globally on Talent, Learning, Human Resources, and Organization Development. Ms. Rollins has served hundreds of companies during her career at Deloitte, where she held various leadership positions in their U.S. Technology, Media, and Telecommunications practice, Audit Innovation and Transformation, and Diversity and Inclusion initiatives. Both executives bring decades of experience in technology, talent, finance, and governance to OpenSesame. Dr. Elkeles has spent 30 years in the human capit

      8/10/22 9:00:00 AM ET
      $DLB
      $GPX
      $SNCE
      $XMTR
      Multi-Sector Companies
      Miscellaneous
      Other Consumer Services
      Consumer Services
    • Dolby Laboratories Announces Dr. Shriram Revankar as SVP Advanced Technology Group

      SAN FRANCISCO, May 03, 2022 (GLOBE NEWSWIRE) -- Dolby Laboratories, Inc. (NYSE:DLB), a leader in immersive entertainment experiences, today announced the appointment of Dr. Shriram Revankar, a technologist and industry leader who has cultivated teams across multiple disciplines to deliver high impact technologies and world-class research, as its Senior Vice President Advanced Technology Group. Shriram will lead Dolby's global Advanced Technology Group building on the company's decades of innovation. Most recently, as Vice President and Fellow at Adobe, Shriram founded several of Adobe's global research labs, including the Big-Data Experience Lab and the Document Intelligence Lab. Through

      5/3/22 12:00:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Appoints Tony Prophet to its Board of Directors

      SAN FRANCISCO, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Dolby Laboratories, Inc. (NYSE:DLB) announced today the appointment of Tony Prophet to its Board of Directors, effective December 6, 2021. Over the course of many years, Tony has established himself as a technology industry leader who has helped guide companies across multiple disciplines. Most recently, Tony served as the Chief Equality and Recruiting Officer at Salesforce, co-chairing the Salesforce Racial Equality and Justice Task Force, created to help drive systemic change in the workplace and community. He was also a co-founder of the company's Ethical and Humane Use of technology initiative. During his time with Microsoft, Tony serve

      12/8/21 8:30:00 AM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous